Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8526
PUT
TAL Education Group
TAL
$7.08B
| $675K | ﹤0.01% |
59,400
+14,100
| +31% | +$159K |
2016 Q2
39 quarters
|
|
8527
Eagle Bancorp Montana
EBMT
$167M
| $675K | ﹤0.01% |
+32,803
| New | +$699K |
2026 Q1
0 quarters
|
|
8528
Goldman Sachs Future Health Care Equity ETF
GDOC
$18.2M
| $675K | ﹤0.01% |
20,692
+909
| +5% | +$31.2K |
2025 Q4
1 quarter
|
|
8529
CALL
KBR
KBR
$4.27B
| $675K | ﹤0.01% |
18,300
-1,000
| -5% | -$41.1K |
2013 Q2
51 quarters
|
|
8530
PUT
indie Semiconductor
INDI
$635M
| $674K | ﹤0.01% |
209,400
+52,500
| +33% | +$185K |
2021 Q2
19 quarters
|
|
8531
CALL
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$10.9B
| $674K | ﹤0.01% |
+17,100
| New | +$695K |
2026 Q1
0 quarters
|
|
|
XMAG
8532
Defiance Large Cap ex-Mag 7 ETF
XMAG
$199M
| $674K | ﹤0.01% |
+30,318
| New | +$693K |
2026 Q1
0 quarters
|
|
8533
PUT
Geron
GERN
$771M
| $673K | ﹤0.01% |
451,900
-80,900
| -15% | -$123K |
2013 Q2
51 quarters
|
|
8534
CALL
Rigel Pharmaceuticals
RIGL
$896M
| $673K | ﹤0.01% |
24,900
-21,700
| -47% | -$729K |
2020 Q3
22 quarters
|
|
8535
Orange County Bancorp
OBT
$497M
| $673K | ﹤0.01% |
+21,050
| New | +$670K |
2026 Q1
0 quarters
|
|
|
AQLT
8536
iShares MSCI Global Quality Factor ETF
AQLT
$344M
| $672K | ﹤0.01% |
24,306
-13,798
| -36% | -$398K |
2025 Q4
1 quarter
|
|
8537
Matthews Emerging Markets ex China Active ETF
MEMX
$58.2M
| $672K | ﹤0.01% |
+16,851
| New | +$692K |
2026 Q1
0 quarters
|
|
|
TCPB
8538
Thrivent Core Plus Bond ETF
TCPB
$474M
| $671K | ﹤0.01% |
13,230
+8,443
| +176% | +$434K |
2025 Q1
4 quarters
|
|
|
JMG
8539
DELISTED
JM Group Ltd
JMG
| $671K | ﹤0.01% |
101,555
-1,113
| -1% | -$7.53K |
2025 Q4
1 quarter
|
|
8540
PUT
Farmers National Banc Corp
FMNB
$892M
| $671K | ﹤0.01% |
+51,000
| New | +$670K |
2026 Q1
0 quarters
|
|
8541
CALL
National Health Investors
NHI
$3.14B
| $671K | ﹤0.01% |
8,300
-4,600
| -36% | -$383K |
2018 Q1
32 quarters
|
|
8542
Criteo S.A.
CRTO
$730M
| $671K | ﹤0.01% |
37,429
-5,137
| -12% | -$96.6K |
2025 Q3
2 quarters
|
|
8543
CALL
iShares US Financials ETF
IYF
$3.77B
| $671K | ﹤0.01% |
5,700
+3,400
| +148% | +$422K |
2022 Q2
15 quarters
|
|
8544
CALL
Badger Meter
BMI
$3.6B
| $670K | ﹤0.01% |
4,400
+100
| +2% | +$15.7K |
2021 Q4
17 quarters
|
|
8545
Neumora Therapeutics
NMRA
$88M
| $670K | ﹤0.01% |
343,586
-162,217
| -32% | -$420K |
2025 Q4
1 quarter
|
|
|
THNR
8546
Amplify Weight Loss Drug & Treatment ETF
THNR
$5.68M
| $670K | ﹤0.01% |
+27,241
| New | +$694K |
2026 Q1
0 quarters
|
|
8547
PUT
Arqit Quantum
ARQQ
$392M
| $669K | ﹤0.01% |
50,500
+7,000
| +16% | +$132K |
2025 Q1
4 quarters
|
|
8548
PUT
Alkami Technology
ALKT
$1.51B
| $669K | ﹤0.01% |
42,700
+27,900
| +189% | +$514K |
2022 Q4
13 quarters
|
|
8549
USCF Gold Strategy Plus Income Fund
USG
$9.38M
| $669K | ﹤0.01% |
18,110
-8,081
| -31% | -$313K |
2025 Q4
1 quarter
|
|
|
VRTL
8550
CALL
GraniteShares 2x Long VRT Daily ETF
VRTL
$41.8M
| $669K | ﹤0.01% |
19,800
-19,500
| -50% | -$570K |
2025 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.